Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors. (Q38052726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

title

Fetal serotonin reuptake inhibitor antidepressant exposure: maternal and fetal factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Alison K Shea

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

Dan Rurak

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

Canadian Journal of Psychiatry

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

523-529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

Psychiatric disorders in pregnant and postpartum women in the United States

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Prevalence of depression during pregnancy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Third Trimester Fetal Heart Rate and Doppler Middle Cerebral Artery Blood Flow Velocity Characteristics During Prenatal Selective Serotonin Reuptake Inhibitor Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Pharmacokinetics of sertraline across pregnancy and postpartum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Inhibition and induction of human cytochrome P450 enzymes: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Clinical implications of drug interactions with coxibs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Antibiotic therapy in preterm premature rupture of the membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

How to manage hypertension in pregnancy effectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

The influence of smoking on the serum level of duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Comparative aspects of trophoblast development and placentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

DrugBank: a comprehensive resource for in silico drug discovery and exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Physiology of amniotic fluid volume regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/070674371205700902

10.1177/070674371205700902

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23073029 AND SRC:MED&resulttype=core&format=json

15 February 2020

1 reference